PD12-12 TUMOR ANTIGEN VACCINE ENHANCES ANTI-TUMOR EFFECTS OF IMMUNE CHECKPOINT INHIBITORS AGAINST REFRACTORY CANCERS

MLA

Shohei Ueda, et al. “Pd12-12 Tumor Antigen Vaccine Enhances Anti-Tumor Effects of Immune Checkpoint Inhibitors against Refractory Cancers.” Journal of Urology, vol. 207, May 2022. EBSCOhost, https://doi.org/10.1097/ju.0000000000002538.12.

APA

Shohei Ueda, Miho Ushjima, Atsushi Irie, Yasuharu Nishimura, & Masatoshi Eto. (2022). Pd12-12 Tumor Antigen Vaccine Enhances Anti-Tumor Effects of Immune Checkpoint Inhibitors against Refractory Cancers. Journal of Urology, 207. https://doi.org/10.1097/ju.0000000000002538.12

Chicago

Shohei Ueda, Miho Ushjima, Atsushi Irie, Yasuharu Nishimura, and Masatoshi Eto. 2022. “Pd12-12 Tumor Antigen Vaccine Enhances Anti-Tumor Effects of Immune Checkpoint Inhibitors against Refractory Cancers.” Journal of Urology 207 (May). doi:10.1097/ju.0000000000002538.12.